Wendy Huisman

Wendy Huisman is currently the Head of Patient Safety at Avanzanite Bioscience since August 2022. She also holds positions as EU Qualified Person for Pharmacovigilance (EU QPPV) and Senior Pharmacovigilance Consultant at Deciphera Pharmaceuticals, as well as a Course director, trainer and program committee member at DIA. Wendy is a Program Committee Member of the MSc Pharmacovigilance at the University of Hertfordshire and an Advisory Board Member at Pharmacovigilance Platform Netherlands (PPN). Previously, she has held roles as Deputy EU Qualified Person for Pharmacovigilance (QPPV) at Seagen, Chair of Pharmacovigilance Focus group at EUCOPE, and EU Qualified Person for Pharmacovigilance at Kiadis Pharma. Wendy has a PharmD in Pharmacy from Utrecht University and a Postgraduate Diploma in Drug Development Sciences from the University of Surrey.